Pharmacotherapy of degenerative joint diseases in the dog;Pharmakotherapie degenerativer gelenkerkrankungen beim hund

Tierarztliche Praxis Ausgabe K: Kleintiere - Heimtiere

Volumn 26, Issue 1, 1998, Pages 1-6

  Klee, Sabine ^a   Ungemach, F R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Chondroprotective drugs; Glucocorticoids; Non steroidal antiinflammatory drugs

Indexed keywords

CANIS FAMILIARIS;

GLUCOSAMINE; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ANIMAL; ANIMAL DISEASE; ARTHROPATHY; ARTICULAR CARTILAGE; DOG; DOG DISEASE; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; DOG DISEASES; DOGS; GLUCOSAMINE; HUMANS; HYALURONIC ACID; JOINT DISEASES; STEROIDS;

EID: 0031990743     PISSN: 14341239     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Beckmann R, Flohe L. The pathogenic role of superoxide radicals in inflammation. Efficacy of exogenous superoxide dismutase. Bull Europ Physiopath Resp 1981; 17 (Suppl): 275-85.
2. Bragt PC, Bonta I. Indomethacin inhibits the formation of the lipoxygenase product HETE during granulomatous inflammation in the rat. J Pharmacy Pharmacol 1980; 32: 143-4.
3. Famaey JP. Recent developments about non-steroidal antiinflammatory drugs and their mode of action. Gen Pharmacol 1978; 9: 155-61.
4. Frölich JC. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isozymes. TiPS January 1997; 18: 30-4.
5. Forth W, Henschler D, Rummel W, Starke K. Allgemeine und spezielle Pharmakologie und Toxikologie. Mannheim: BI Wissenschaftsverlag 1992; 320-33.
6. Kalbhen DA, Blum U, Schiller G. Experimental osteoarthrosis induced by antirheumatic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 1976; Suppl 293: R 40.
7. Kuemmerle H-P, Hitzenberger G, Spitzy KH (Hrsg). Klinische Pharmakologie. Pharmakotherapie des Bewegungsapparates. Landsberg, München: ecomed. 1984; 43. Erg.Lfg. 10/94. IV-4.18.
8. Löscher W, Ungemach FR, Kroker R. Pharmakotherapie bei Haus-und Nutztieren. Berlin: Parey 1997; 319-49.
9. Niemand H, Suter P (Hrsg). Praktikum der Hundeklinik. Berlin: Parey 1994; 696-8.
10. Nohl H. Die pathophysiologischen Grundlagen der Therapie verschiedener klinischer Erkrankungen mit dem körpereigenen Enzym Superoxiddismutase. Wien Tierärztl Mschr 1982; 11: 301-8.
11. Siegel MI, McConnell R-T, Porter NA, Cuatrecasas P. Arachidonate metabolism via lipoxygenase and 12-L-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Proc Nat Acad Sci 1979; 76: 3774-8.
12. Vane JR, Mitchell JA, Appleton I. Inducible isoforms of cyclooxygenase and nitric-oxide synthetase in inflammation. Proc Natl Acad Sci USA 1994; 91: 2046-50.